InsiderClue
Stocks · Health care · Pharmaceutical Preparations

XBiotech Inc.

XBIT Clue Score31
United States Fiscal year ends December CIK 0001626878
$2.29 +4.09% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.29 −82.60% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Operating income−52.8Net income−52.8Fiscal year 2017Operating income−34.1Net income−33.2EPS, diluted−0.95Fiscal year 2018Revenue0.0Operating income−21.0Net income−21.1EPS, diluted−0.59Fiscal year 2019Revenue0.0Operating income−31.2Net income668.6EPS, diluted14.44Fiscal year 2020Revenue44.0Operating income−18.3Net income−11.2 −101.7%EPS, diluted−0.36Fiscal year 2021Revenue18.4 −58.2%Operating income−25.1Net income−17.4EPS, diluted−0.58Fiscal year 2022Revenue4.0 −78.2%Operating income−34.5Net income−32.9EPS, diluted−1.08Fiscal year 2023Revenue0.0 −100.0%Operating income−37.5Net income−24.6EPS, diluted−0.81Fiscal year 2024Operating income−42.5Net income−38.5EPS, diluted−1.26Fiscal year 2025Operating income−55.7Net income−45.5EPS, diluted−1.49
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.0 0.0 44.0 18.4 4.0 0.0 n/a n/a
Growth −58.2% −78.2% −100.0%
Operating income −52.8 −34.1 −21.0 −31.2 −18.3 −25.1 −34.5 −37.5 −42.5 −55.7
Net income −52.8 −33.2 −21.1 668.6 −11.2 −17.4 −32.9 −24.6 −38.5 −45.5
Growth −101.7%
EPS, diluted n/a −0.95 −0.59 14.44 −0.36 −0.58 −1.08 −0.81 −1.26 −1.49

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Fiscal year 2019Fiscal year 2020Gross margin21.5%Operating margin−41.5%Net margin−25.5%Free cash flow margin−156.5%Fiscal year 2021Gross margin68.4%Operating margin−136.4%Net margin−94.7%Free cash flow margin358.4%Fiscal year 2022Gross margin83.8%Operating margin−860.1%Net margin−820.4%Free cash flow margin−384.3%Fiscal year 2023Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a 21.5% 68.4% 83.8% n/a n/a n/a
Operating margin n/a n/a n/a n/a −41.5% −136.4% −860.1% n/a n/a n/a
Net margin n/a n/a n/a n/a −25.5% −94.7% −820.4% n/a n/a n/a
Free cash flow margin n/a n/a n/a n/a −156.5% 358.4% −384.3% n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−46.0Capital expenditure−4.7Free cash flow−50.8Fiscal year 2017Operating cash flow−33.6Capital expenditure−1.4Free cash flow−35.1Fiscal year 2018Operating cash flow−16.5Capital expenditure−0.1Free cash flow−16.7Fiscal year 2019Operating cash flow−18.3Capital expenditure−0.2Free cash flow−18.5Dividends paid0.0Fiscal year 2020Operating cash flow−65.1Capital expenditure−3.7Free cash flow−68.9Dividends paid0.0Fiscal year 2021Operating cash flow69.4Capital expenditure−3.5Free cash flow65.9Dividends paid−75.0Fiscal year 2022Operating cash flow−14.8Capital expenditure−0.6Free cash flow−15.4 −123.4%Buybacks0.0Dividends paid0.0Fiscal year 2023Operating cash flow−18.7Capital expenditure−0.4Free cash flow−19.1Buybacks−0.0Fiscal year 2024Operating cash flow−31.0Capital expenditure−1.3Free cash flow−32.3Buybacks0.0Fiscal year 2025Operating cash flow−39.9Capital expenditure−0.3Free cash flow−40.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −46.0 −33.6 −16.5 −18.3 −65.1 69.4 −14.8 −18.7 −31.0 −39.9
Capital expenditure −4.7 −1.4 −0.1 −0.2 −3.7 −3.5 −0.6 −0.4 −1.3 −0.3
Free cash flow −50.8 −35.1 −16.7 −18.5 −68.9 65.9 −15.4 −19.1 −32.3 −40.2
Growth −123.4%
Buybacks n/a n/a n/a n/a n/a n/a 0.0 −0.0 0.0 n/a
Dividends paid n/a n/a n/a 0.0 0.0 −75.0 0.0 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash34.3Shareholders’ equity59.1Fiscal year 2017Cash31.8Shareholders’ equity60.2Fiscal year 2018Cash15.8Shareholders’ equity41.4Fiscal year 2019Cash714.6Shareholders’ equity755.6Fiscal year 2020Cash237.4Shareholders’ equity348.6Fiscal year 2021Cash237.0Shareholders’ equity269.4Fiscal year 2022Cash157.3Shareholders’ equity240.4Fiscal year 2023Cash200.0Shareholders’ equity218.8Fiscal year 2024Cash172.7Shareholders’ equity182.3Fiscal year 2025Cash125.6Shareholders’ equity140.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 34.3 31.8 15.8 714.6 237.4 237.0 157.3 200.0 172.7 125.6
Shareholders’ equity 59.1 60.2 41.4 755.6 348.6 269.4 240.4 218.8 182.3 140.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a 0.0 0.0 44.0 18.4 4.0 0.0 n/a n/a
Growth −58.2% −78.2% −100.0%
n/a n/a 0.0 0.0 34.5 5.8 0.7 0.0 n/a n/a
n/a n/a 0.0 0.0 9.4 12.6 3.4 0.0 n/a n/a
Growth +33.1% −73.3% −100.0%
42.5 26.4 15.7 24.1 9.5 28.3 31.5 32.8 37.8 47.4
10.3 7.6 5.3 7.1 18.2 9.4 6.3 4.7 4.7 8.3
−52.8 −34.1 −21.0 −31.2 −18.3 −25.1 −34.5 −37.5 −42.5 −55.7
Growth
−52.8 −33.2 −21.1 718.5 −12.8 −25.5 −33.6 −24.3 −38.6 −45.3
0.0 0.0 0.0 49.8 −1.6 −8.0 −0.7 0.2 −0.0 0.2
−52.8 −33.2 −21.1 668.6 −11.2 −17.4 −32.9 −24.6 −38.5 −45.5
Growth −101.7%
Per share
n/a −0.95 −0.59 17.17 −0.36 −0.58 −1.08 −0.81 −1.26 −1.49
n/a −0.95 −0.59 14.44 −0.36 −0.58 −1.08 −0.81 −1.26 −1.49
Growth −102.5%
n/a 34.9 35.8 38.9 30.8 30.0 30.4 30.4 30.5 30.5
n/a 34.9 35.8 46.3 30.8 30.0 30.4 30.4 30.5 30.5
Growth +2.7% +29.4% −33.5% −2.5% +1.3% −0.0% +0.1% +0.1%

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 9 of 10 years on file.